Announcing o11's backing from Y Combinator.
Pharmaceutical R&D: Automating Clinical Trial Reporting with o11
For Pharmaceutical and Biotech companies, the gap between “Lab Data” and “Board Approval” is often paved with thousands of PowerPoint slides. Researchers and Clinical Operations teams spend an inordinate amount of time moving data from SAS or Excel into formatted reporting decks.
o11 is the automation layer for the scientific enterprise.
From Raw Results to Research Decks
1. Data-to-Graphic Sync
Clinical trial results are high-stakes and dense. o11 allows researchers to link their analysis workbooks directly to their “Phase II Review” decks. If the p-value or the efficacy data is updated in the source file, the slide chart updates automatically—eliminating the risk of manual transcript error.
2. Regulatory Compliance Slides
Safety reporting requires strict formatting. o11 can take a standardized “Adverse Events” table and ensure it is formatted exactly to the required internal compliance standards across 50 different slides.
3. Executive Summaries for Grant Funding
When BioTech startups are pitching for Series C or grant funding, they need to distill months of research into a 10-slide narrative. o11 reads the research whitepapers and suggests the most compelling visual representations of the data to include in the pitch.
Why BioTech Chooses o11
The “Error-Free” nature of o11’s data links is critical when a single misplaced decimal can stall a regulatory filing.
